BIOmaterials for Modelling, Engineering and Novel Discovery
We "mend" the human body with biomaterials, from building advanced biomaterial-based tissue models, to developing novel therapies for complex diseases, and uncovering new frontiers in biomaterial-cell interactions to modulate pathology evolution and ageing at molecular and genetic levels.
Understanding how biomaterials interact with cells and tissues at a biological level to cure disease or prevent aging.
Developing targeted nanotechnology therapies for metastatic cancers, including ovarian cancer.
Creating smart biomaterials to promote cartilage regeneration and treat osteoarthritis.
Developing advanced nanotechnology-based therapies for diabetic foot ulcers and chronic wound healing.
Building human-relevant 3D skin models to study fibrosis, ageing, and chronic skin pathologies.
The 3 most recent updates from our lab.
July 27, 2026
Our collaborative paper, "Force-responsive biomaterials drive tissue repair by harnessing endogenous growth factors", was published in Nature Materials. DOI: 10.1038/s41563-026-02682-8.
2026
BIOMEND LAB was awarded a CaixaImpulse Innovation project to spin out our injectable cartilage-regenerating technology.
April 16, 2026
Our collaborative paper, "Chronic insulin exposure induces EMT-associated changes and increases migration and invasion in cancer cells", was published in Advances in Cancer Biology - Metastasis. DOI: 10.1016/j.adcanc.2026.100184.
We're always looking for motivated scientists and engineers to join our group. Contact us to discuss opportunities!
View Open Positions